The WHO estimates the average medication adherence rate is 50% in developed nations, though the U.S. trails other countries in reported adherence on Medisafe.…


FiercePharmaAsia: WuXi AppTec subsidiary’s IPO, Mezzion’s lawsuit against Dr. Reddy’s, Eisai’s liver cancer med, and more

Eisai's Lenvima moves toward Nexavar showdown with phase 3 liver cancer win

FDA delivers Form 483 to Eisai plant in U.S.

Arena dumps laggard weight-loss med Belviq onto marketing partner Eisai

Pfizer's Ibrance faces tough review at NICE, U.K. exec worries

Pharma already balks at Germany's tough pricing regime--and it could get even tougher

Eisai wins NICE backing for older Halaven but still isn't happy about Lenvima

NICE says Merck KGaA's Erbitux falls short in mouth cancer, despite new discount, data

NICE spurns Merck's pricey Keytruda in lung cancer on worries about extended treatment

AstraZeneca's Tagrisso wins CDF coverage, marking a 'breakthrough moment' in England